A Novel Metabolic Connectome Method to Predict Progression to Mild Cognitive Impairment

OBJECTIVE: Glucose-based positron emission tomography (PET) imaging has been widely used to predict the progression of mild cognitive impairment (MCI) into Alzheimer's disease (AD) clinically. However, existing discriminant methods are unsubtle to reveal pathophysiological changes. Therefore, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Min, Yan, Zhuangzhi, Xiao, Shu-yun, Zuo, Chuantao, Jiang, Jiehui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450311/
https://www.ncbi.nlm.nih.gov/pubmed/32908613
http://dx.doi.org/10.1155/2020/2825037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7450311/
https://www.ncbi.nlm.nih.gov/pubmed/32908613
http://dx.doi.org/10.1155/2020/2825037

Ejemplares similares